# cGMP Mitragynine HCl Supplemental Stability & Analytical Activities

Canonical: https://abierto.us/opportunities/75n95024q00480

- Solicitation number: 75N95024Q00480
- Notice type: Combined synopsis and solicitation
- Status: Awarded to Curia Global Inc.
- Department: Department of Health and Human Services
- Agency: National Institutes of Health
- Contracting office: National Institutes of Health Nida (75N950)
- NAICS: 541380 Testing Laboratories and Services
- Product or service code: B504 Chemical/Biological Studies and Analysis
- Place of performance: Albany, New York
- County: Albany County (FIPS 36001). https://abierto.us/counties/albany-county-ny-36001
- City: Albany. https://abierto.us/cities/albany-ny-3601000
- First posted: August 7, 2024
- Last posted: August 7, 2024
- SAM.gov: https://sam.gov/workspace/contract/opp/a2b5470efb094112bde07eeb592d9a8b/view

## Description

This is a combined synopsis/solicitation for commercial items prepared in accordance with the format in Subpart 12.6 as supplemented with additional information included in this notice. This announcement constitutes the only solicitation; proposals are being requested and a written solicitation will not be issued. The solicitation number is 75N95024Q00480 and the solicitation is issued as a request for quotation (RFQ).

This acquisition is for a commercial item or service and is conducted under the authority of the Federal Acquisition Regulation (FAR) Part 13—Simplified Acquisition Procedures; and FAR Part 12—Acquisition of Commercial Items, and is not expected to exceed the simplified acquisition threshold. THIS IS A NON-COMPETITIVE (NOTICE OF INTENT) COMBINED SYNOPSIS SOLICITATION TO AWARD A CONTRACT OR PURCHASE ORDER WITHOUT PROVIDING FOR FULL OR OPEN COMPETITION (INCLUDING BRAND-NAME).

The National Institute on Drug Abuse (NIDA), Office of Acquisition (OA), on behalf of the National Center for Advancing Translational Sciences (NCATS), intends to negotiate and award a purchase order without providing for full and open competition (including brand-name) to Curia Global, Inc., 26 Corporate Circle Albany, New York 12203 for cGMP Mitragynine HCl Supplemental Stability & Analytical Activities.

This acquisition is conducted as non-competitive for a commercial item or service and is conducted pursuant to FAR 13.106-1(b)(1). The Therapeutic Development Branch (TDB) at the National Center for Advancing Translational Sciences (NCATS) is conducting a preclinical development of Mitragynine (MG) to support its clinical evaluation, as part of the Helping to End Addiction Long-term initiative (HEAL).

The Contractor shall provide long term stability studies on two cGMP batches of Mitragynine HCl and requalify cGMP reference standard of Mitragynine HCl annually for up to 3 years. See Attachment 1 - Statement of Work.

## Award on USAspending

- Recipient: Curia Global Inc. (UEI ELCNZCS8GEA3)
- Contract: 75N95024P00489, purchase order
- Obligated: $96,200.00
- Competition: Not Competed Under SAP, 1 offers received
- Link: solicitation number 75N95024Q00480 equals the FPDS solicitation identifier; same awarding office 75N950 (high confidence)
- Record: https://www.usaspending.gov/award/CONT_AWD_75N95024P00489_7529_-NONE-_-NONE-/


## Publications

- August 7, 2024: Combined synopsis and solicitation, due August 15, 2024 at 12:00 PM EDT. Notice a2b5470efb094112bde07eeb592d9a8b. https://sam.gov/workspace/contract/opp/a2b5470efb094112bde07eeb592d9a8b/view

## Points of contact

- Sarah Adan, sarah.adan@nih.gov, 3014805422

---
Source: SAM.gov Contract Opportunities bulk extract and USAspending.gov award data. Confirm deadlines on SAM.gov before responding. Cite https://abierto.us/opportunities/75n95024q00480.